alzheon, Author at Alzheon | Preserving Future Memories - Page 11 of 21

About alzheon

This author has not yet filled in any details.
So far alzheon has created 202 blog entries.

3 Feb, 2020

Is Targeting Oligomers in APOE4 Homozygotes the Path Forward in Alzheimer’s Disease?

alzheon2020-08-21T20:16:04-04:00February 3rd, 2020|

17 Jan, 2020

Neurodegenerative Treatments Build to a Tipping Point

alzheon2020-08-21T20:16:49-04:00January 17th, 2020|

7 Jan, 2020

Alzheon Announces Appointments of Noel Dunn, Jordan Heller, and Diane Jorkasky, MD, to Board of Directors

alzheon2024-08-05T13:46:40-04:00January 7th, 2020|

7 Jan, 2020

Alzheon Announces Appointment of Peter N. Laivins as Head of Commercial Strategy and Planning

alzheon2024-08-26T10:52:17-04:00January 7th, 2020|

3 Jan, 2020

The path forward in Alzheimer’s disease therapeutics: Reevaluating the amyloid cascade hypothesis

alzheon2024-06-19T16:32:55-04:00January 3rd, 2020|

2 Dec, 2019

APOE4/4 Subjects with Early Alzheimer’s Disease Show Accelerated Loss of Cortical Thickness and Cognitive Decline Compared to APOE3/3 Subjects

alzheon2019-11-27T16:57:28-05:00December 2nd, 2019|

2 Dec, 2019

Alzheon Announces Scientific Presentation at 12th CTAD Conference Taking Place on December 4-7 in San Diego, USA

alzheon2024-08-02T13:12:07-04:00December 2nd, 2019|

6 Nov, 2019

Alzheon Gets Closer to Alzheimer’s Drug Treatment

alzheon2024-08-09T11:11:21-04:00November 6th, 2019|Tags: cheddar.com|

6 Nov, 2019

Alzheon Publication Defines New Path for 2nd Generation Anti-Amyloid Drugs for Alzheimer’s Disease, Supporting Launch of Phase 3 Study with ALZ-801 Oral Tablet

alzheon2024-08-02T13:03:06-04:00November 6th, 2019|

6 Nov, 2019

New Alzheon Publication Points to a More Positive Future for Alzheimer’s Drug Development

alzheon2024-08-09T11:04:59-04:00November 6th, 2019|